<table id="sdowy"><acronym id="sdowy"><thead id="sdowy"></thead></acronym></table>

    <b id="sdowy"><address id="sdowy"></address></b>
      <rp id="sdowy"></rp>

        日本語中文

        30

        its market to more than 30 provinces and cities

        500

        over 500 tertiary hospitals

        1000

        over 1,000 communities and secondary hospitals

        5

        turnover of exceeding RMB 500 million

        Pharmaceutical sales service

               As a wholly-owned subsidiary of Huawei Pharmaceutical Group Co., Ltd., Beijing Huawei Medical LLC is responsible for the sales and market of medical products. With a hard-working sales team of outstanding expertise and marketing experience, the Company has expanded its market to more than 30 provinces and cities, including over 500 tertiary hospitals and over 1,000 communities and secondary hospitals and promoted its products of pediatrics, pneumology, oncology, hematology, gynecology, orthopedics, hepatology and gastroenterology internal medicine with an annual turnover of exceeding RMB 500 million. Meanwhile, the Company has established long-term strategic partnerships with plenty of pharmaceutical companies. Its operation philosophy is “win-win cooperation”, “providing excellent service” and “serving as a good partner”.


        Development of new product and technology

               Huawei Pharmaceutical Development and Consulting (Beijing) Co., Ltd. is a wholly-owned subsidiary of Huawei Pharmaceutical Group Co., Ltd. Targeting at medical programs failing to meet patients' demands and with the Medical Excellence Japan (MEJ) as a strategic partner, the company is developing world-leading medical products and introducing globally advanced medical programs for the benefit of people's health, based on cooperation in medical products developed by Japan. Now, we have introduced Cefcapene Pivoxil Hydrochloride Granules from Japan’s Shionogi Inc.

               Since 2017, we have carried out multiple exchanges and cooperation with PMDA, MEJ, Japanese Medical Association, etc.

         

        Introduction and development of pharmaceutical products
        Introduction and development of pharmaceutical products

        We cooperate with Japanese pharmaceutical and medical device companies to develop businesses and establish projects of pharmaceutical products introduced.

        Registration of pharmaceutical products
        Registration of pharmaceutical products

        In addition to self-developed products, we serve as an agent for pharmaceutical products of domestic and foreign companies, develop products and register them for marketing.

        Clinical research
        Clinical research

        We implement clinical research of pharmaceutical products to support domestic and foreign pharmaceutical companies.

        Policy consulting
        Policy consulting

        We help domestic and foreign pharmaceutical companies connect with the pharmaceutical regulatory authority and implement policy consulting activities on product development, registration and so on.

        Product Investment
        Product Investment

        We assist pharmaceutical companies in China and Japan to conduct investment, cooperation and joint research and development of new products in the frontier of pharmaceutical innovation.


        Mobile phone

        Wechat

        ADD:2812/2815/2816/2817, Nanyin building, No. 2, East Third Ring North Road, Chaoyang District, Beijing
        Tel:+86-10-61006202/61006203
        Fax:+86-10-61006309
        URL:www.pinwusheji.com.cn 

        Copyright(C)2022,Huawei Pharmaceutical Group All Rights Reserved.
         Supported by Toocle 31fabu Copyright Notice

        激情五月天在线一区,熟妇人妻中文字幕无码老熟妇,一本色道久久88综合亚洲精品,中文字幕无码视频手机免费看
        <table id="sdowy"><acronym id="sdowy"><thead id="sdowy"></thead></acronym></table>

          <b id="sdowy"><address id="sdowy"></address></b>
            <rp id="sdowy"></rp>